Form 4 for RMD ResMed|
Accepted 2022-04-12 00:00:00 ET · period of report 2022-04-11 · accession 0001127602-22-011914 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-12 | 2022-04-11 | RMD | Sandercock Brett | CFO | S - Sale+OE | $247.00 | -2,500 | 106.4K | -2% | -$617.5K |
| D | 2022-04-12 | 2022-04-11 | RMD | Sandercock Brett | CFO | M - OptEx | $57.76 | +2,500 | 108.9K | +2% | +$144.4K |
| D | 2022-04-12 | 2022-04-11 | RMD | Sandercock Brett | CFO | M - OptEx | $0.00 | -2,500 | 10.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-04-11 | S | D | 2,500 | $247.00 | 106,354 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2022-04-11 | M | A | 2,500 | $57.76 | 108,854 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2022-04-11 | M | D | 2,500 | $0.00 | 10,000 | D | $57.76 · 2017-11-11 to 2023-11-16 | 2,500 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest 1/3 per year. |